PRESS RELEASE published on 07/08/2024 at 07:56, 2 years 2 months ago AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19 AB Science annonce des résultats positifs de son étude de phase 2 évaluant le masitinib dans la COVID-19. Les analyses montrent un potentiel traitement prometteur pour les patients hospitalisés COVID-19 Traitement Étude De Phase 2 AB Science Masitinib
BRIEF published on 06/28/2024 at 12:36, 2 years 2 months ago AB Science fait le point sur la demande d'autorisation du masitinib dans la SLA Autorisation De Mise Sur Le Marché AB Science Masitinib EMA SLA
BRIEF published on 06/28/2024 at 12:36, 2 years 2 months ago AB Science provides an update on the application for authorization of masitinib in ALS ALS AB Science Masitinib EMA Marketing Authorization
PRESS RELEASE published on 06/28/2024 at 12:31, 2 years 2 months ago AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA AB Science annonce un avis négatif sur la demande de mise sur le marché du masitinib dans la SLA et prévoit un réexamen du dossier. Détails sur les raisons et les prochaines étapes AB Science Masitinib Sclérose Latérale Amyotrophique Autorisation Conditionnelle Réexamen Dossier
PRESS RELEASE published on 06/28/2024 at 12:31, 2 years 2 months ago AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS AB Science receives negative opinion from CHMP on masitinib's conditional marketing authorization for ALS treatment but plans re-examination due to urgent patient need and safety considerations AB Science Masitinib CHMP ALS Treatment Conditional Marketing Authorization
BRIEF published on 06/27/2024 at 10:20, 2 years 2 months ago AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024 Actionnaires Capital Social Assemblée Générale Resolutions AB Science
BRIEF published on 06/27/2024 at 10:20, 2 years 2 months ago AB Science - Results of the Combined General Meeting of June 26, 2024 Shareholders Share Capital Resolutions General Assembly AB Science
PRESS RELEASE published on 06/27/2024 at 10:15, 2 years 2 months ago AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024 Assemblée Générale Mixte de AB Science du 26 juin 2024 : toutes les résolutions ordinaires et extraordinaires adoptées sauf une. Actionnariat présent : 21.948.183 actions ordinaires et 38.495.615 droits de vote Actionnaires Droits De Vote Assemblée Générale Resolutions AB Science
BRIEF published on 05/17/2024 at 18:03, 2 years 4 months ago Correction des Comptes Consolidés de AB Science pour 2023 Résultats Financiers Recherche Et Développement Comptes Consolidés AB Science Correction Comptable
BRIEF published on 05/17/2024 at 18:03, 2 years 4 months ago Correction of the Consolidated Accounts of AB Science for 2023 Financial Results Research And Development Consolidated Accounts AB Science Accounting Correction
Published on 09/19/2026 at 00:55, 14 hours 45 minutes ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 15 hours 50 minutes ago Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 17 hours 40 minutes ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 19 hours 5 minutes ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 1 day 1 hour ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/19/2026 at 13:15, 2 hours 25 minutes ago Eurobattery Minerals AB has received information regarding court judgment and criminal suspicion concerning the CEO
Published on 09/19/2026 at 07:30, 8 hours 9 minutes ago Hong Kong sets out initiatives to secure long-term development of pillar industries
Published on 09/18/2026 at 18:44, 20 hours 55 minutes ago EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million
Published on 09/18/2026 at 18:13, 21 hours 27 minutes ago Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:34, 21 hours 5 minutes ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 21 hours 5 minutes ago Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Published on 09/18/2026 at 17:45, 21 hours 55 minutes ago Press Release_Carrefour Bond_September 2026
Published on 09/18/2026 at 17:45, 21 hours 55 minutes ago Communiqué de presse_Carrefour Bond_Septembre 2026